BetterLife Pharma Inc. cotiza a 0.17 USD y tiene una capitalización bursátil de $108M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
BetterLife Pharma Inc., a biotechnology company, engages in the development of psychedelic-derived compounds. It focuses on developing and commercializing BETR-001, a non-hallucinogenic and non-controlled LSD derivative to treat neuro-psychiatric and neurological disorders. Its products also comprise MM-001, a topical …
| Métrica | BETRF | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -260.6% | -40.4% | -220.2% |
| ROA | -106.4% | -32.0% | -74.4% |
| Current Ratio | — | 2.84 | — |
| Debt / Equity | — | 0.28 | — |